Abstract
Purpose
The majority of newly diagnosed renal tumors are masses < 4 cm in size with treatment options, including active surveillance, partial nephrectomy, and ablative therapies. The cost-effectiveness literature on the management of small renal masses (SRMs) does not account for recent advances in technology and improvements in technical expertise. We aim to perform a cost-effectiveness analysis for percutaneous microwave ablation (MWA) and robotic-assisted partial nephrectomy (RA-PN) for the treatment of SRMs.
Methods
We created a decision analytic Markov model depicting management of the SRM incorporating costs, health utilities, and probabilities of complications and recurrence as model inputs using TreeAge. A willingness to pay (WTP) threshold of $100,000 and a lifetime horizon were used. Probabilistic and one-way sensitivity analyses were performed.
Results
Percutaneous MWA was the preferred treatment modality. MWA dominated RA-PN, meaning it resulted in more quality-adjusted life years (QALYs) at a lower cost. Cost-effectiveness analysis revealed a negative Incremental Cost-Effectiveness Ratio (ICER), indicating dominance of MWA. The model revealed MWA had a mean cost of $8,507 and 12.51 QALYs. RA-PN had a mean cost of $21,521 and 12.43 QALYs. Relative preference of MWA was robust to sensitivity analysis of all other variables. Patient starting age and cost of RA-PN had the most dramatic impact on ICER.
Conclusion
MWA is more cost-effective for the treatment of SRM when compared with RA-PN and accounting for complication and recurrence risk.
Similar content being viewed by others
Abbreviations
- AS:
-
Active surveillance
- ICER:
-
Incremental cost-effectiveness ratio
- MWA:
-
Microwave ablation
- NMB:
-
Net monetary benefit
- QALYs:
-
Quality-adjusted life years
- RA-PN:
-
Robotic-assisted partial nephrectomy
- SRM:
-
Small renal mass
- WTP:
-
Willingness to pay
References
Howlader, N.N., AM; Krapcho, M; Miller, D; Brest, A; Yu, M; Ruhl, J; Tatalovich, Z; Mariotto, A; Lewis, DR; Chen, HS; Feuer, EJ; Cronin, KA, SEER cancer statistics review, 1975–2017, National Cancer Institute. Bethesda, MD, 2020: p. 1–12.
Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2018. 68(6): p. 394–424.
Campbell, S., et al., Renal Mass and Localized Renal Cancer: AUA Guideline. The Journal of urology, 2017. 198: p. 520.
Zhou, W., et al., Radiofrequency ablation, cryoablation, and microwave ablation for T1a renal cell carcinoma: a comparative evaluation of therapeutic and renal function outcomes. Journal of Vascular and Interventional Radiology, 2019. 30(7): p. 1035-1042.
Martin, J. and S. Athreya, Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome? Diagnostic and interventional radiology, 2013. 19(6): p. 501.
De Cobelli, F., et al., Percutaneous microwave ablation versus cryoablation in the treatment of T1a renal tumors. Cardiovascular and interventional radiology, 2020. 43(1): p. 76-83.
Papanicolas, I., L.R. Woskie, and A.K. Jha, Health care spending in the United States and other high-income countries. Jama, 2018. 319(10): p. 1024-1039.
Keehan, S.P., et al., National health expenditure projections, 2014–24: spending growth faster than recent trends. Health Affairs, 2015. 34(8): p. 1407-1417.
Dieleman, J.L., et al., US spending on personal health care and public health, 1996-2013. Jama, 2016. 316(24): p. 2627-2646.
Emanuel, E.J., Where are the health care cost savings? Jama, 2012. 307(1): p. 39-40.
Chang, S.L., et al., Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. The Journal of urology, 2011. 185(5): p. 1591-1597.
Weinstein, M.C., et al., Recommendations of the Panel on Cost-effectiveness in Health and Medicine. Jama, 1996. 276(15): p. 1253-1258.
Neumann, P.J., et al., Cost-effectiveness in health and medicine. 2016: Oxford University Press.
Yeaman, C., et al., Perioperative Cost Comparison Between Percutaneous Microwave Ablation vs Partial Nephrectomy for Small Renal Masses. Urology Practice, 2021. 8(6): p. 630-635.
Mershon, J.P., M.N. Tuong, and N.S. Schenkman, Thermal ablation of the small renal mass: a critical analysis of current literature. Minerva urologica e nefrologica= The Italian journal of urology and nephrology, 2019.
Hu, X., et al., Partial nephrectomy versus ablative therapies for cT1a renal masses: a systematic review and meta-analysis. European Journal of Surgical Oncology, 2019. 45(9): p. 1527-1535.
Zhou, W. and R.S. Arellano, Thermal ablation of T1c renal cell carcinoma: a comparative assessment of technical performance, procedural outcome, and safety of microwave ablation, radiofrequency ablation, and cryoablation. Journal of Vascular and Interventional Radiology, 2018. 29(7): p. 943-951.
Choi, S.H., et al., Efficacy and safety of microwave ablation for malignant renal tumors: an updated systematic review and meta-analysis of the literature since 2012. Korean journal of radiology, 2018. 19(5): p. 938.
Sotimehin, A.E., et al., Selecting patients with small renal masses for active surveillance: a domain based score from a prospective cohort study. The Journal of urology, 2019. 201(5): p. 886-892.
Metcalf, M.R., et al., Outcomes of active surveillance for young patients with small renal masses: prospective data from the DISSRM registry. The Journal of urology, 2021. 205(5): p. 1286-1293.
Pandharipande, P.V., et al., Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology, 2010. 256(3): p. 836-846.
Taplin, S.H., et al., Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. JNCI: Journal of the National Cancer Institute, 1995. 87(6): p. 417–426.
Mouraviev, V., et al., Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours≤ 3.5 cm: a single institutional experience. European urology, 2007. 51(3): p. 715–721.
Yong, C., et al., Outcomes of Microwave Ablation for Small Renal Masses: A Single Center Experience. Journal of Endourology, 2020. 34(11): p. 1134-1140.
Yu, J., et al., Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: a propensity-matched cohort study of 1955 patients. Radiology, 2020. 294(3): p. 698-706.
Jones*, C., et al., PD08–09 MICROWAVE ABLATION VERSUS CRYOTHERAPY FOR THE ABLATION OF T1A RENAL MASSES: A TERTIARY CARE CENTER RETROSPECTIVE REVIEW. The Journal of Urology, 2020. 203(Supplement 4): p. e171-e172.
Guan, W., et al., Microwave ablation versus partial nephrectomy for small renal tumors: Intermediate‐term results. Journal of surgical oncology, 2012. 106(3): p. 316-321.
Connor, J., et al., Postoperative complications after robotic partial nephrectomy. Journal of endourology, 2020. 34(1): p. 42-47.
Chehab, M., et al., Percutaneous cryoablation vs partial nephrectomy: cost comparison of T1a tumors. Journal of endourology, 2016. 30(2): p. 170-176.
Castle, S.M., et al. Cost comparison of nephron-sparing treatments for cT1a renal masses. in Urologic Oncology: Seminars and Original Investigations. 2013. Elsevier.
Anglickis, M., et al., Microwave thermal ablation versus open partial nephrectomy for the treatment of small renal tumors in patients over 70 years old. Medicina, 2019. 55(10): p. 664.
Shao, N., et al., Causes of death and conditional survival of renal cell carcinoma. Frontiers in oncology, 2019. 9: p. 591.
Neumann, P.J., et al., Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med, 2014. 371(9): p. 796-797.
Funding
No funds, grants, or other support were received. The authors have no relevant financial or non-financial interests to disclose.
Author information
Authors and Affiliations
Contributions
CY participated in the project development, data analysis, interpretation of data, and manuscript writing/editing, RM participated in the data collection or management and manuscript writing/editing, JML participated in the project development, data analysis, interpretation of data, and manuscript writing/editing, ADN participated in the data collection or management and manuscript writing/editing, LOC participated in the data collection or management and manuscript writing/editing, TW participated in the project development, data analysis, interpretation of data, and manuscript writing/editing, CB participated in the interpretation of data and manuscript writing/editing, DLL participated in the interpretation of data and manuscript writing/editing, AM participated in the interpretation of data and manuscript writing/editing, NSS participated in the project development, Interpretation of data, and manuscript writing/editing, All authors meet criteria for definitions of authorship as defined by ICMJE.
Corresponding author
Ethics declarations
Conflict of interest
No disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yeaman, C., Marchant, R., Lobo, J.M. et al. Cost-effectiveness analysis: percutaneous microwave ablation vs robotic-assisted partial nephrectomy for small renal masses. Abdom Radiol 48, 411–417 (2023). https://doi.org/10.1007/s00261-022-03692-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03692-1